Morphologic and Functional Dual-Energy CT Parameters in Patients With Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease

被引:9
|
作者
Bin Saeedan, Mnahi [1 ]
Bullen, Jennifer [2 ]
Heresi, Gustavo A. [3 ]
Rizk, Alain [1 ]
Karim, Wadih [1 ]
Renapurkar, Rahul D. [1 ]
机构
[1] Cleveland Clin, Sect Thorac & Cardiovasc Imaging Lab, Imaging Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Pulm & Crit Care Med, Resp Inst, Cleveland, OH 44195 USA
关键词
hypertension; MDCT; pulmonary; pulmonary embolism; LUNG PERFUSION; BLOOD-VOLUME; EMBOLISM;
D O I
10.2214/AJR.19.22743
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to compare morphologic and functional dual-energy CT (DECT) parameters in patients with chronic thromboembolic disease (CTED) and chronic thromboembolic pulmonary hypertension (CTEPH). MATERIALS AND METHODS. Using the local CI'EPH registry, we identified 28 patients with CTED and 72 patients with CTEPH. On each DECT examination, a clot burden score was calculated by assigning the following scores for chronic changes by location: pulmonary trunk, 5; each main pulmonary artery (MPA), 4; each lobar branch, 3; each segmental branch, 2; and each subsegmental branch, 1. The total clot burden score was calculated by adding the individual scores from both lungs. Functional parameters were assessed using perfused blood volume (PBV) maps and included lung enhancement (in Hounsfield units), percentage of PBV, MPA peak enhancement (in Hounsfield units), maximum enhancement corresponding to 100, and the ratio of MPA peak enhancement to lung enhancement. A perfusion defect (PD) score was calculated by assigning 1 point to each segmental PD. Patients with CTED and patients with CTEPH were matched using propensity score matching to account for potential confounders. RESULTS. After matching, the CTEPH group showed a higher PD score than the CTED group and unilateral disease was more common in the CTED group than in the CTEPH group. In the unmatched sample, patients with CTED showed increased percentages of PBV for both lungs (PBV total) and for the right lung as compared with the CTEPH group (adjusted p = 0.040 and 0.028, respectively); after adjustment for clot burden, the difference between groups was still noted but was not statistically significant. No statistically significant differences were noted in the various functional DWI' parameters after propensity score matching. CONCLUSION. Patients with CTED show anatomic and functional changes in the pulmonary vasculature and lung parenchyma similar to those seen in patients with CTEPH. Functional DECT parameters support the observation that CTED is an intermediate clinical phenotype in the population with chronic pulmonary embolism.
引用
收藏
页码:1335 / 1341
页数:7
相关论文
共 50 条
  • [41] Chronic thromboembolic pulmonary hypertension
    Fedullo, PF
    Auger, WR
    Channick, RN
    Kerr, KM
    Rubin, LJ
    CLINICS IN CHEST MEDICINE, 2001, 22 (03) : 561 - +
  • [42] Chronic thromboembolic pulmonary hypertension
    Auger, WR
    Kerr, KM
    Kim, NHS
    Ben-Yehuda, O
    Knowlton, KU
    Fedullo, PF
    CARDIOLOGY CLINICS, 2004, 22 (03) : 453 - +
  • [43] Chronic thromboembolic pulmonary hypertension
    Guth, Stefan
    Wilkens, Heinrike
    Halank, Michael
    Held, Matthias
    Hobohm, Lukas
    Konstantinides, Stavros
    Omlor, Albert
    Seyfarth, Hans-Juergen
    Schaefers, Hans-Joachim
    Mayer, Eckhard
    Wiedenroth, Christoph B.
    PNEUMOLOGIE, 2023, 77 (11): : 937 - 946
  • [44] Chronic thromboembolic pulmonary hypertension
    Dartevelle, P
    Fadel, E
    Mussot, S
    Chapelier, A
    Hervé, P
    de Perrot, M
    Cerrina, J
    Ladurie, FL
    Lehouerou, D
    Humbert, M
    Sitbon, O
    Simonneau, G
    EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (04) : 637 - 648
  • [45] Chronic thromboembolic pulmonary hypertension
    Hoeper, Marius M.
    Madani, Michael M.
    Nakanishi, Norifumi
    Meyer, Bernhard
    Cebotari, Serghei
    Rubin, Lewis J.
    LANCET RESPIRATORY MEDICINE, 2014, 2 (07): : 573 - 582
  • [46] Chronic Thromboembolic Pulmonary Hypertension
    Teerapuncharoen, Krittika
    Bag, Remzi
    LUNG, 2022, 200 (03) : 283 - 299
  • [47] Chronic thromboembolic pulmonary hypertension
    B. E. Schölzel
    R. J. Snijder
    J. J. Mager
    H W. van Es
    H. W. M. Plokker
    H. J. Reesink
    W. J. Morshuis
    M. C. Post
    Netherlands Heart Journal, 2014, 22 : 533 - 541
  • [48] Chronic thromboembolic pulmonary hypertension
    Scholzel, B. E.
    Snijder, R. J.
    Mager, J. J.
    van Es, Hw.
    Plokker, H. W. M.
    Reesink, H. J.
    Morshuis, W. J.
    Post, M. C.
    NETHERLANDS HEART JOURNAL, 2014, 22 (12) : 533 - 541
  • [49] Chronic Thromboembolic Pulmonary Hypertension
    Olsson, Karen M.
    Meyer, Bernhard
    Hinrichs, Jan
    Vogel-Claussen, Jens
    Hoeper, Marius M.
    Cebotari, Serghei
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2014, 111 (50): : 856 - 862
  • [50] Chronic Thromboembolic Pulmonary Hypertension
    Buck, Emory
    Kearns, Sean
    Dahhan, Talal
    Parikh, Kishan S.
    Krasuski, Richard A.
    Rajagopal, Sudarshan
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2024, 20 (03) : 188 - 201